Bone and joint health supplements market to be worth over $9 billion by 2017

NewsGuard 100/100 Score

A globally ageing population, changing consumer lifestyles and a focus on preventative medicine is driving growth in the bone and joint health supplements market, which is forecast to be worth over $9 billion by 2017. Rising incidence of bone and joint conditions combined with escalating medical costs are promoting interest in nutrition and supplements, according to a new report available on companiesandmarkets.com.

Bone and Joint Health Supplements: A Global Strategic Business Report

The demand for natural health and food supplements is increasing, as consumers take preventative measures to combat bone and joint conditions such as bone fractures, calcium loss, osteoporosis and osteoarthritis. Segments examined within the report include: Glucosamine-Chondroitin Supplements (witnessing a decline in share), Calcium Supplements (which hold the largest market share) and Other Supplements.

A recent trend noted within the bone and joint supplements market has been the success of 'combination' products, such as glucosamine with omega-3 fatty acids, and glucosamine with MSM (methylsulfonylmethane).

The last few years have seen consolidation within the healthcare supplements market for example, DuPont's acquisition of Danisco, Glanbia's acquisition of BSN, and DSM's takeover of Martek Biosciences.

The largest bone health and joint health market is the US, followed by Japan. The Asia-Pacific region will display most rapid growth over the reporting period at 6.8% CAGR, encouraged by China's hold over the market as the world's largest producer of glucosamine. This region will also lead market growth of calcium, vitamins, soy isoflavones and other supplements, along with other developing markets.

Over 90 key players in the joint supplements and bone supplements market are profiled within the report, including: Bergstrom Nutrition, Inc, DSM Nutritional Products Ltd, ESM Technologies LLC, Kappa Bioscience AS, Navamedic ASA, Schiff Nutrition International, Inc and Zhejiang Freeman Shinfuda Co. Ltd.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Scientists regenerate fully functional urinary bladder tissue using a non-human primate model